Prevalence of Sensitization to Legumes in a Region From Southern France (Légumineuses)
NCT ID: NCT03686891
Last Updated: 2022-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2000 participants
INTERVENTIONAL
2018-01-24
2022-09-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impacts of Lentils on Metabolism and Inflammation
NCT04283448
Effect of Oat Compounds on Postprandial Glucose Response
NCT05177172
Meta-analyses of the Effect of Legumes on Blood Pressure
NCT02600338
The NutriNet-Santé Study
NCT03335644
Effects of Legumes on Glucose Regulation
NCT01706042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Skin prick tests with four native legumes
Skin prick tests with four native legumes
Skin prick tests with four native legumes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Skin prick tests with four native legumes
Skin prick tests with four native legumes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient (or parents for the under 18 years) must have given their free consent and signed the consent chart
* Men and women are included
* The patient is at least 2 years old
Exclusion Criteria
* The patient is breast-feeding
* The patient is unable to stop in antihistamine medication for at least 7 days
* The patient refused or is unable to sign the consent chart
* The patient has a dermographism
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service Exploration des allergologies-Hopital Arnaud de Villeneuve-CHU de Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9776
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.